RA0070

antibody from Oursmab
Targeting: CD19
Provider product page for RA0070
Western blot
ELISA
Immunocytochemistry
Flow cytometry
Functional assay

Antibody data

Product number
RA0070 - Provider product page
Provider
Oursmab
Product name
Coltuximab (Biosimilar Reference Antibody) (CD19)
Antibody type
Monoclonal
Description
Coltuximab (also known as SAR3419) is an investigational antibody-drug conjugate (ADC) developed for the treatment of B-cell non-Hodgkin lymphoma (NHL). It is designed to deliver a potent cytotoxic agent specifically to cancer cells expressing the CD19 antigen, a hallmark of B-cell malignancies. Clinical trials have evaluated its efficacy, particularly in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), aiming to provide a targeted therapeutic option for this aggressive disease.
Reactivity
Human
Isotype
IgG
Vial size
100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg
Concentration
Bottled at the concentration indicated on the vial.
Storage
Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.
CD19 protein structure - RA0070 shown in red.